{"database": "openregs", "table": "federal_register", "rows": [["2012-24331", "New Animal Drugs; Butorphanol; Doxapram; Triamcinolone; Tylosin", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of a new animal drug application (NADA) and three abbreviated new animal drug applications (ANADAs) at the sponsors' request because the products are no longer manufactured or marketed.", "2012-10-03", 2012, 10, "https://www.federalregister.gov/documents/2012/10/03/2012-24331/new-animal-drugs-butorphanol-doxapram-triamcinolone-tylosin", "https://www.govinfo.gov/content/pkg/FR-2012-10-03/pdf/2012-24331.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of a new animal drug application (NADA) and three abbreviated new animal drug applications (ANADAs) at the sponsors' request because the...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2012-24331"], "units": {}, "query_ms": 0.509809935465455, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}